Idera Pharmaceuticals (IDRA) News Today → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free IDRA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEkso Bionics (NASDAQ: EKSO)fool.com - April 11 at 12:41 PMKiniksa Pharmaceuticalsforbes.com - November 15 at 3:23 PMNabriva Therapeutics AG (NBRVF)investing.com - August 9 at 2:08 AMMarginalianpr.org - April 26 at 9:17 PMA mysterious rift propels the story in ‘Take What You Need’washingtonpost.com - March 17 at 5:57 PMIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic Outlookfinanznachrichten.de - January 18 at 7:34 AMIdera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic Outlookfinance.yahoo.com - January 17 at 11:33 AMWhy Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionmsn.com - January 10 at 7:29 PMIdera (IDRA) Stock Soars on GlaxoSmithKline Partnershipthestreet.com - January 4 at 12:55 PMIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 18 at 3:52 PMIdera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 14 at 5:55 PMIdera Pharma Acquires Rare Disease Player, Names New CEOfinance.yahoo.com - September 29 at 3:46 PMIdera Pharma Shares Rise Nearly 18% After Aceragen Acquisitionmarketwatch.com - September 28 at 6:34 PMIdera Pharmaceuticals Acquires Aceragenfinance.yahoo.com - September 28 at 6:34 PMIdera Pharmaceuticals Stock (NASDAQ:IDRA), Dividendsbenzinga.com - September 27 at 10:32 PMIdera Pharmaceuticals Reports Second Quarter 2022 Financial Resultsfinance.yahoo.com - August 9 at 9:26 PMIdera halts melanoma trial for cancer candidate after early positive resultsseekingalpha.com - May 17 at 6:10 PMWhy Are Idera Pharmaceuticals Shares Soaring Todayfinance.yahoo.com - May 17 at 6:10 PMIdera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCfinance.yahoo.com - May 17 at 8:18 AMIdera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 5 at 6:17 PMIdera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 31 at 6:36 PMIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Sees Large Increase in Short Interestmarketbeat.com - January 3 at 3:42 PMIdera Shares Fall After Early Tilsotolimod Data, Seeks Collaborating Partners For TLR9 Agonistmsn.com - December 15 at 10:25 AMIdera Pharmaceuticals Announces Tilsotolimod Updatesfinance.yahoo.com - December 14 at 6:39 PM5 Penny Stocks To Buy According To Analysts & Targets Up To 341%chron.com - December 8 at 7:08 PMIdera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 8 at 8:48 PMIdera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 9 at 8:20 PM Get Idera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss. Click here now for the full story. IDRA Media Mentions By Week IDRA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDRA News Sentiment▼0.000.34▲Average Medical News Sentiment IDRA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDRA Articles This Week▼00▲IDRA Articles Average Week Get Idera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Editas Medicine News Today Humacyte News Today Taysha Gene Therapies News Today C4 Therapeutics News Today Alvotech News Today Voyager Therapeutics News Today Lexeo Therapeutics News Today Replimune Group News Today iTeos Therapeutics News Today Alector News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDRA) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupHis win rate puts Warren Buffett to shame… Investing DailyTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
